← Back to all signals
RESEARCH PAPER ANALYSIS

Communication Challenges and Strategies in Adolescent and Young Adult Cancer Survivorship Care: A Qualitative Study of Clinician Perspectives.

Interviews with 12 survivorship clinicians identified communication barriers—including information burden, limited time, and anxiety—and strategies such as rapport building, accessible language, visual aids, and contextualization of risk and uncertainty in AYA cancer survivorship care.

Open original publication →
PMID42695467
JournalJournal of adolescent and young adult oncology
Publication Date2026-09-04
Ingested2026-09-06 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

Interviews with 12 survivorship clinicians identified communication barriers—including information burden, limited time, and anxiety—and strategies such as rapport building, accessible language, visual aids, and contextualization of risk and uncertainty in AYA cancer survivorship care.

WHY IT MATTERS

Research significance

The study provides qualitative evidence that clinicians perceive tailored, clear, rapport-based communication as supportive of AYA engagement; it remains an untested inference that formal communication interventions or clinician training based on these themes would improve adherence, psychosocial well-being, or long-term health outcomes.

ABSTRACT

Source abstract

PURPOSE: Adolescent and young adult (AYA) cancer survivors treated in pediatric settings face long-term physical and psychosocial effects from cancer treatment, and lifelong specialized survivorship care is recommended. Prior research has focused on what survivors need to know about past cancer and future health, with less emphasis on how clinicians communicate with AYAs and families. This study evaluated effective communication strategies and challenges with survivorship-related communication according to experienced clinicians. METHODS: We conducted individual interviews with survivorship clinicians from diverse practice settings across the United States between November 2024 and February 2025. Interviews queried communication strategies, barriers, and recommendations for improving clinical interactions with AYA survivors. Qualitative analysis identified key themes and patterns. RESULTS: Clinicians (nine females and three males), in practice for 4-37 years, were physicians specializing in pediatric oncology (N = 7; two with med-peds training), primary care with a survivorship focus (N = 3), or nurse practitioners (N = 2). Barriers to effective communication included information complexity and volume, lack of time, and anxiety among AYA survivors and families. Effective communication strategies included building rapport, a mindset to "meet the patient where they're at," use of clear, accessible language with visual aids, and contextualizing information about health risks and associated uncertainty. Findings illustrated ways that clinician communication may promote or inhibit AYA engagement in survivorship care. CONCLUSION: Effective communication between clinicians and AYA cancer survivors may improve health outcomes by helping survivors understand health risks, managing associated uncertainty and anxiety, and promoting AYA engagement in survivorship care. This study will inform the development of communication interventions and training for clinicians.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Prevalence and Associations for Use of Complementary and Alternative Medicine (CAM) Among Paediatric Cancer Patients in Norway: A Cross-Sectional Survey. Integrative cancer therapies 69.0 2 Portal cavernoma: epidemiological, clinical, etiological and outcome profiles - a 15-year retrospective study in a University Hospital in Rabat, Morocco. The Pan African medical journal 63.5 3 Artificial intelligence in Vietnamese healthcare: public awareness, demand, and willingness to pay. BMC health services research 60.2 4 Xp11.2 Translocation Renal Cell Carcinoma in an Elderly Woman: A Diagnostic Challenge - A Case Report. Case reports in oncology 49.0 5 The unbalanced needs and perceived supply of supportive care in family caregivers of patients with multiple myeloma: a cross-sectional study. BMC palliative care 59.9 6 Development and Optimization of 111 In-Dinutuximab-IRDye800, a Dual-Modality Intraoperative Molecular Imaging Agent for Pediatric Neuroblastoma Resection. bioRxiv : the preprint server for biology 77.4 7 High-Resolution Subtyping of Pediatric Low-Grade Glioma Using an Integrated Meta-Clustering Framework. bioRxiv : the preprint server for biology 67.5 8 Concordance of rapid whole genome and targeted long read sequencing of pediatric brain tumors with standard clinical testing. Research square 61.9 9 Synergistic targeting of EP300/CBP and EYA co-activators collapses the rhabdomyosarcoma core regulatory circuit. bioRxiv : the preprint server for biology 57.6 10 Clinical Presentation of, Treatment Approaches for, and the Impact of Social Determinants of Health on Pediatric Catatonia: A Structured Qualitative Synthesis and Targeted Literature Review. Cureus 66.04 11 Sequential Philadelphia-Positive Pre-B Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia With Distinct BCR::ABL1 Fusion Transcripts. Cancer reports (Hoboken, N.J.) 67.1 12 Intracranial germ cell tumours presenting with AVP deficiency and evolving panhypopituitarism: diagnostic pitfalls in early imaging and biopsy. Endocrinology, diabetes & metabolism case reports 64.0 13 A Subset of FOXO1-Fusion Negative Rhabdomyosarcoma With Round Cell (Alveolar) and "Burkitt-Like" Morphology Is Associated With High Amplification of MYCL: A Report From the Children's Oncology Group. Genes, chromosomes & cancer 57.5 14 Pediatric lynch-associated melanoma arising in ovarian teratoma: a case report. Gynecologic oncology reports 55.1 15 Case Report: Case series: growth hormone replacement for severe growth hormone deficiency during BRAF inhibitor therapy in pediatric low-grade glioma: long-term follow-up. Frontiers in endocrinology 70.3 16 Prognostic value of lymph node ratio in children with wilms tumor: a systematic review and meta-analysis. Frontiers in oncology 79.6 17 Real-world efficacy and safety of efgartigimod in patients with autoimmune encephalitis: a single-center retrospective analysiss. Frontiers in immunology 69.1 18 Combined aromatherapy and music or sound for emotional distress: a systematic review of controlled studies published between 2019 and 2026. Frontiers in psychology 84.84 19 Longitudinal follow-up of autoimmune neutropenia in adults-a single-cohort experience. Frontiers in immunology 69.8 20 A spectrum of tumorigenesis in an IDH1-mosaic patient with Ollier disease, acute myeloid leukaemia, and parathyroid adenoma. Frontiers in genetics 57.0 21 From armed-conflict to care: clinical outcomes, diagnostic challenges, and psychosocial burden in children evaluated for suspected cancer displaced from Gaza and treated at a regional center of excellence. Frontiers in oncology 68.2 22 Clinical and radiological features of posterior reversible encephalopathy syndrome in children: a retrospective study. Frontiers in pediatrics 69.3 23 Case Report: Cytomegalovirus-associated granulomatous lung disease in an immunocompetent preterm infant. Frontiers in immunology 47.5 24 Atypical echocardiographic phenotype of end-stage hypertrophic cardiomyopathy: a case series. Frontiers in cardiovascular medicine 57.0 25 Utilizing BRAF/MEK Inhibitors to Reduce Morbidity in a Pediatric Patient With Ameloblastoma: A Case Report. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 55.26 26 EWSR1-FLI1 expression combined with monoallelic EWSR1 depletion is associated with mitotic spindle damage and nocodazole sensitivity. Biology open 53.3 27 Real-World Outcomes of Total Body Irradiation versus Chemotherapy-Based Conditioning in Pediatric Acute Lymphoblastic Leukemia. Clinical epidemiology 74.84 28 Structure and Function of Archaeal SRP54 Protein Mutants Associated with Human Severe Congenital Neutropenia. ACS omega 55.0 29 Minibeam Radiotherapy in Pediatric Cancer: First Clinical Use in a Treatment-Refractory Sarcoma. Pediatric blood & cancer 58.3 30 Refractory Idiopathic Infantile Pyoderma Gangrenosum Successfully Treated With Infliximab: A Case Report. Case reports in pediatrics 61.72 31 Prospective evaluation of serum methotrexate pharmacokinetics following intrathecal methotrexate in acute lymphoblastic leukaemia. British journal of haematology 62.8 32 Gradient-driven microfluidic framework for the screening of ratiometric drug combinations towards precision oncology in paediatric leukaemia. Nature biomedical engineering 64.16
PATIENT-FRIENDLY SUMMARY

Communication Challenges and Strategies in Adolescent and Young Adult Cancer Survivorship Care: A Qualitative Study of Clinician Perspectives.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic